secwatch.observer — SEC 8-K summary
======================================

Issuer:     LIFECORE BIOMEDICAL, INC. DE (LFCR)
CIK:        0001005286
Form:       8-K
Filed at:   2024-01-05T23:59:59+00:00
Accession:  0001005286-24-000004
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 2.03, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lifecore expands Alcon CDMO contract through 2031; receives credit waivers on delayed reports
--------------------------------------------------------------------------------

- Entered 8-year Amended CMA with Alcon through Dec 2031 for aseptic manufacturing of ophthalmic devices.
- Alcon gets option to purchase new filter dryer to expand HA capacity; costs paid by Alcon.
- Alcon and BMO granted waivers on delayed financial reporting under Term Loan and Revolving Credit agreements.
- Strategic alternative review remains ongoing; no timetable or decision set.
- Company expects to file overdue 2023 10-K in near-term.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1005286/000100528624000004/0001005286-24-000004-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1005286/000100528624000004/lndc-20231231.htm
  HTML page:      https://secwatch.observer/filing/0001005286-24-000004

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer